JP2022533182A5 - - Google Patents
Info
- Publication number
- JP2022533182A5 JP2022533182A5 JP2021568650A JP2021568650A JP2022533182A5 JP 2022533182 A5 JP2022533182 A5 JP 2022533182A5 JP 2021568650 A JP2021568650 A JP 2021568650A JP 2021568650 A JP2021568650 A JP 2021568650A JP 2022533182 A5 JP2022533182 A5 JP 2022533182A5
- Authority
- JP
- Japan
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024145040A JP2024170457A (ja) | 2019-05-16 | 2024-08-27 | タンパク質キナーゼ阻害剤ならびに疾患および状態の治療のためのその使用 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962848648P | 2019-05-16 | 2019-05-16 | |
| US201962848719P | 2019-05-16 | 2019-05-16 | |
| US62/848,648 | 2019-05-16 | ||
| US62/848,719 | 2019-05-16 | ||
| PCT/US2020/032784 WO2020232190A1 (en) | 2019-05-16 | 2020-05-14 | Protein kinase inhibitors and uses thereof for the treatment of diseases and conditions |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024145040A Division JP2024170457A (ja) | 2019-05-16 | 2024-08-27 | タンパク質キナーゼ阻害剤ならびに疾患および状態の治療のためのその使用 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022533182A JP2022533182A (ja) | 2022-07-21 |
| JP2022533182A5 true JP2022533182A5 (https=) | 2023-05-02 |
| JPWO2020232190A5 JPWO2020232190A5 (https=) | 2023-05-02 |
| JP7546603B2 JP7546603B2 (ja) | 2024-09-06 |
Family
ID=70919255
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021568650A Active JP7546603B2 (ja) | 2019-05-16 | 2020-05-14 | タンパク質キナーゼ阻害剤ならびに疾患および状態の治療のためのその使用 |
| JP2024145040A Pending JP2024170457A (ja) | 2019-05-16 | 2024-08-27 | タンパク質キナーゼ阻害剤ならびに疾患および状態の治療のためのその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024145040A Pending JP2024170457A (ja) | 2019-05-16 | 2024-08-27 | タンパク質キナーゼ阻害剤ならびに疾患および状態の治療のためのその使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US12516055B2 (https=) |
| EP (2) | EP4480485A3 (https=) |
| JP (2) | JP7546603B2 (https=) |
| AU (1) | AU2020275304B2 (https=) |
| CA (1) | CA3137869A1 (https=) |
| WO (1) | WO2020232190A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11174255B2 (en) * | 2017-05-15 | 2021-11-16 | University Of Houston System | Pyrido[2,3-d]pyrimidin-7-ones and related compounds as inhibitors of protein kinases |
| EP4480485A3 (en) * | 2019-05-16 | 2025-02-26 | University of Houston System | Protein kinase inhibitors and uses thereof for the treatment of diseases and conditions |
| CN113072471B (zh) * | 2021-03-02 | 2022-09-16 | 四川美大康华康药业有限公司 | 一种利非司特中间体及其制备方法 |
| WO2024097805A1 (en) * | 2022-11-01 | 2024-05-10 | Trustees Of Tufts College | Mixed lineage kinase domain like pseudokinase (mlkl) activators |
| WO2024199388A1 (zh) * | 2023-03-29 | 2024-10-03 | 微境生物医药科技(上海)有限公司 | 作为myt1抑制剂的化合物 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL117923A (en) | 1995-05-03 | 2000-06-01 | Warner Lambert Co | Anti-cancer pharmaceutical compositions containing polysubstituted pyrido¬2,3-d¾pyrimidine derivatives and certain such novel compounds |
| US6150359A (en) * | 1997-08-20 | 2000-11-21 | Warner-Lambert Company | Naphthyridinones for inhibiting protein tyrosine kinase and cell cycle kinase mediated cellular proliferation |
| KR20020070520A (ko) | 2000-01-27 | 2002-09-09 | 워너-램버트 캄파니 | 신경퇴행성 질병의 치료를 위한 피리도피리미디논 유도체 |
| WO2014031571A1 (en) * | 2012-08-21 | 2014-02-27 | Icahn School Of Medicine At Mount Sinai | Treatment of viral infections |
| WO2015179436A1 (en) | 2014-05-19 | 2015-11-26 | Sanford-Burnham Medical Research Institute | Inflammation therapy using mekk3 inhibitors or blocking peptides |
| US11174255B2 (en) | 2017-05-15 | 2021-11-16 | University Of Houston System | Pyrido[2,3-d]pyrimidin-7-ones and related compounds as inhibitors of protein kinases |
| EP4480485A3 (en) * | 2019-05-16 | 2025-02-26 | University of Houston System | Protein kinase inhibitors and uses thereof for the treatment of diseases and conditions |
-
2020
- 2020-05-14 EP EP24191377.1A patent/EP4480485A3/en active Pending
- 2020-05-14 JP JP2021568650A patent/JP7546603B2/ja active Active
- 2020-05-14 WO PCT/US2020/032784 patent/WO2020232190A1/en not_active Ceased
- 2020-05-14 AU AU2020275304A patent/AU2020275304B2/en active Active
- 2020-05-14 US US17/595,406 patent/US12516055B2/en active Active
- 2020-05-14 EP EP20729566.8A patent/EP3968991B1/en active Active
- 2020-05-14 CA CA3137869A patent/CA3137869A1/en active Pending
-
2024
- 2024-08-27 JP JP2024145040A patent/JP2024170457A/ja active Pending